Evidence map›Paper›PMID 39004382›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2024

Aryl hydrocarbon receptor (AhR)-mediated immune responses to degeneration of the retinal pigment epithelium.

James Regun Karmoker, Sarah E Bounds, Jiyang Cai

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James Regun KarmokerDepartment of Biochemistry & Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: james-karmoker@ouhsc.edu.
Sarah E BoundsDepartment of Biochemistry & Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: sarah-bounds@ouhsc.edu.
Jiyang CaiDepartment of Biochemistry & Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: jiyang-cai@ouhsc.edu.

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Metabolic reprogramming of endothelial precursor cells in subretinal fibrosisR01EY034742 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JIYANG CAI, Jian-Xing Jay Ma · 2023 to 2026
$1.8M
NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY034742
6 · The paper itself

Abstract

Injuries to the retinal pigment epithelium (RPE) trigger immune responses, orchestrating interactions within the innate and adaptive immune systems in the outer retina and choroid. We previously reported that interleukin 17 (IL-17) is a pivotal signaling molecule originating from choroidal γδ T cells, exerting protective effects by mediating functional connections between the RPE and subretinal microglia. In this current study, we generated mice with aryl hydrocarbon receptor (AhR) knockout specifically in IL-17-producing cells. These animals had deficiency in IL-17 production from γδ T cells, and exhibited increased sensitivity to both acute and chronic insults targeting the RPE. These findings imply that IL-17 plays a crucial role as a signaling cytokine in preserving the homeostasis of the outer retina and choroid.

Indexed as

Interleukin-17Receptors, Aryl HydrocarbonRetinal Pigment EpitheliumAnimalsBasic Helix-Loop-Helix ProteinsChoroidIntraepithelial LymphocytesMiceMice, Inbred C57BLMice, KnockoutRetinal DegenerationSignal TransductionAhr protein, mouseBasic Helix-Loop-Helix ProteinsInterleukin-17Receptors, Aryl HydrocarbonAge-related macular degenerationAryl hydrocarbon receptorImmune responseRPE

Identifiers

PMID39004382
PMCPMC11330344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.